Flowhub is Automating Cannabis From Seed to Sale
There is no doubt that the marijuana industry in the US has a lot of growth potential.
Posts Tagged ‘NYSE:ABBV’
Look Beyond Pharma to Invest in Marijuana Industry
In this article we are going to present an alternative to weed stocks such as GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Cara Therapeutics Inc (NASDAQ:CARA), Zynerba Pharmaceuticals...
Market Movers Today: AbbVie Inc (ABBV), Intel Corporation (INTC), Wynn Resorts, Limited (WYNN), and More
AbbVie, the maker of the world's best selling drug, reported fourth-quarter profit on Friday that beat Wall Street estimates on strong sales for its blockbuster drug Humira.
This Is How To Invest in the Marijuana Industry
Marijuana industry in the US is still in its inception phase, but it’s growing, and the projections are very optimistic.
True Leaf Seeks to Raise Capital as It Prepares to Enter into the Booming Canadian Marijuana Market
Canada is undoubtedly one of the greatest countries on earth.
15 Best Selling Most Profitable Drugs of All Time
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Top 10 Largest Pharmaceutical Companies By Revenue in 2017
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
Top 75 Healthcare Dividend Stocks To Invest In
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
15 Biggest Healthcare Companies in USA
If you're seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the 15 biggest healthcare companies...
This Fund’s Picks Gained 200% In A Year And Why No One Knows About It
You probably haven't heard of Alex Denner's Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which its stock picks in companies valued...
10 Most Advanced Technologies In The World Today
Let’s focus on the 10 most advanced technologies in the world today, to highlight the great job done by our scientists and innovators.
In A Blow To AbbVie Inc (ABBV) Humira, Market For Biosimilars Opened Wide
Two patents that AbbVie Inc (NYSE:ABBV) held on Humira, a treatment for arthritis, have been invalidated by an English court.
AbbVie Inc (ABBV) In Share Buyback Plan For The Third Year In A Row
The AbbVie Inc (NYSE:ABBV) board of directors has given the authorization required to increase $5 billion to the company’s existing share buyback program.
UK National Institute For Health And Care Excellence Rejects Leukemia Drug From AbbVie Inc (ABBV)
The National Institute for Health and Care Excellence has refused to authorize AbbVie Inc (NYSE:ABBV)'s Venclyxto on NHS.
Here’s What’s Important About The Latest AbbVie Inc (ABBV) Approval
AbbVie Inc (NYSE:ABBV) just announced that it has picked up approval for one of its lead development candidates, but the company has failed to really move on the announcement.
12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies
Yes, you read the title right there are at least 12 health benefits of medical marijuana according to publicly traded weed companies.
Emergent Technologies’ Pure MHC Explores A New Collaboration With AbbVie Inc (ABBV)
AbbVie Inc (NYSE:ABBV) has sought a joint venture with its target discovery portfolio company, Emergent Technologies Inc, Pure MHC.
Mylan NV (MYL), AbbVie Inc (ABBV) Sanofi SA (ADR) (SNY) In Spotlight Over Price Hikes
A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations.
Billionaire Druckenmiller’s Top Dividend Stock Picks
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros.
AbbVie Inc (ABBV) Awaits NDA Approval For Hepatitis C Treatment
A New Drug Application (NDA) by AbbVie Inc (NYSE:ABBV) that will be used for the treatment of Hepatitis C is at the mercy the U.S. Food and Drug Administration.
Billionaire Larry Robbins Knows How To Pick Mega-Cap Stocks
Larry Robbins’ Glenview Capital Management reported an equity portfolio worth over $13.98 billion in its latest 13F filing.
Billionaire Larry Robbins Confidently Piles Into CBS, Anthem, As Merger Battles Continue
Larry Robbins is a billionaire investor and businessman who founded the New York-based hedge fund Glenview Capital in 2000. Mr.
Is AbbVie Inc (ABBV) A Good Stock To Buy?
Hedge funds are not perfect. They have their bad picks just like everyone else.
Gilead Sciences, Inc. (GILD) Takes Lead Against AbbVie Inc (ABBV) On Crohn’s Disease Treatment
Gilead Sciences, Inc. (NASDAQ:GILD) might as well have quashed rumors making waves claiming it is planning to acquire Belgium-based Galapagos NV (ADR) (NASDAQ:GLPG).
December 2016 Stock Considerations
The final ‘stock considerations’ post of 2016 is finally at hand.
AbbVie Inc (ABBV), Alkermes PLC (ALKS): Will Woodford Investment’s Long Positions Rule the Market Again in Q4?
Woodford Investment Management is a London-based hedge fund founded in 2016 by Neil Woodford.
AbbVie Inc (ABBV) Wins Patent Battle Against Coherus Biosciences Inc (CHRS)
The US Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB) has decided not to embark on the review of the 166 formulation patent of AbbVie Inc (NYSE:ABBV) ...
AbbVie Inc (ABBV) Stock: Skyrocketing On IP Chatter | Coherus Biosciences Inc (CHRS) Stock Tanking
AbbVie Inc (NYSE:ABBV) and Coherus Biosciences Inc (NASDAQ:CHRS) were both off to a relatively normal start in the market today.
November 2016 Stock Considerations
As we near the home stretch of 2016 it seems like Mr. Market wants to give us some better buying opportunities compared to the recent months that have passed.
Trending Stocks: Davita, Nordstrom, AbbVie, and More
Among the stocks that are capturing investors' attention today are Nordstrom, Inc. (NYSE:JWN), AbbVie Inc (NYSE:ABBV), AutoNation, Inc.
Four Dividend Champions On Sale
I usually look at dividend growth stocks and their dividend increases every week, as part of my portfolio monitoring process.
Recent Stock Purchase II October 2016
I always end my ‘Recent Buys’ posts with the caveat that Mr. Market can always spring up some new opportunities not outlined in my monthly considerations posts.
VeriFone (PAY), Genesco (GCO): Analysts Slashed Their Price Targets On These 5 Stocks Last Week
Although the fundamental prospects for many companies are strong given the robust U.S.
AbbVie Inc (ABBV) Expected To Launch Zinbryta In The US This Month
AbbVie Inc (NYSE:ABBV) and Biogen Inc (NASDAQ:BIIB) drug Zinbryta was approved by the Food and Drug Administration (FDA) as a therapy for adults suffering from relapsing forms...
M&A Smorgasbord for NextEra, Plus Earnings Results from Exxon, AbbVie, 2 Other Companies
The Nasdaq and all other major indexes are in the red this morning despite tech heavyweights Amazon.com, Inc.
Finding Reliable 3%+ Dividends in Today’s Market: AbbVie Inc (ABBV)
The financial markets today are filled with sand traps and water hazards; lower for longer crude oil prices, negative interest rate policies (NIRP), slow economic growth, the ...
Why Adamis Pharmaceuticals, Immunomedics and Three Other Stocks Are Deep in Red Today?
Markets are trading higher on Monday, as HSBC Holdings PLC said in a report earlier today that the markets are poised to remain bullish.
Five Dividend Stocks Hedge Funds Love
Oil baron and America's first billionaire John D.
Billionaire Larry Robbins’ Top Healthcare Picks for Q2
Larry Robbins' Glenview Capital has been underperforming the broader market and the overall hedge fund industry for over a year now.
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused hedge fund Baker Bros...
Why These 5 Stocks Are Trending Today
The markets are trading in the red today after investor sentiment was dented following the Labor Department's assertion that the U.S economy inched up by 0.5% in the first quarter...
Tipp Hill Cashes Out of Gold Stocks, Puts It Into Healthcare
Syracuse University graduate Richard L. Haydon named his fund after the Tipperary Hill area, his childhood neighborhood.
Toronto-based Breton Hill Added These 5 Stocks to its Portfolio in Q1
Toronto-based Breton Hill Capital recently submitted its 13F filing with the SEC for the reporting period of March 31, revealing a U.S equity portfolio worth $271.7 million.
Why Are Investors Excited About These 5 Stocks Today?
The markets are going nowhere today, after the IMF cut its global growth forecast for the fourth time over the past twelve months, due to China's slowdown.
Stocks Financial Advisors Are Interested In: Costco, Facebook & More
Last week was marked by the S&P 500 entering into its eighth year of bull run amid an increase in oil prices and hopes of more stimulus from central banks.
Do Hedge Funds Love AbbVie Inc (ABBV)?
After years of low interest rates, retail investors continue to starve for income while awaiting higher yields.
Five Dividend Aristocrats Hedge Funds Are Bullish On
Amid the latest market volatility, dividend investing is one of the safest bets on the equity markets.
AbbVie Inc (ABBV): A Cheap Dividend Aristocrat Yielding Over 4%
AbbVie Inc (NYSE:ABBV) is one of the more controversial dividend aristocrats for several reasons.
The Stock Picks of This Obscure Hedge Fund Returned 70.5% In 2015; See What It’s Betting On in 2016
Although Los Angeles-based, biotech-focused hedge fund DAFNA Capital Management has been in operation for the past 17 years, chances are that very few people have heard its name...
